For those who need a laptop that will be able to handle even the most demanding tasks, you can’t go wrong with the Lenovo ThinkPad X1 Carbon Gen 11. It’s packed with powerful components ...

3 Comments on Lenovo ThinkPad X1 2-in-1 Gen 10 Aura Edition ... system with a pointing stick in the keyboard as well as a three-button trackpad below the keyboard, and support for pressure ...

Lenovo ThinkPad X13 Gen 2 is a Windows 10 laptop with a 13.30-inch display. It is powered by a Ryzen 5000 Series processor. Connectivity options include Wi-Fi 802.11 ac/ax and it comes with 4 USB ...

Another budget-friendly ThinkPad option is the E14. It has some good mid-level specs like an AMD Ryzen 7 processor, 16GB of RAM, and a 512GB solid state drive. But it’s also focused on ...

Novo Nordisk, after mulling the implications of a phase 3 fail, has given up on a late-stage kidney drug acquired in a $1.3 billion deal. The Danish pharma bought the nonsteroidal ...

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial. The Danish ...

X's ballot box "like" is just a cute civic engagement moment. Credit: Alex Wong / Staff / Getty Images News via Getty Images Be wary of candidates claiming victory too soon. Voters may be eager to ...

While the deal would not weigh heavily on Roche’s own production operations, “it could be a problem for other smaller players if there is a restriction in terms of how many CMOs are available ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

As Novo Nordisk’s injectable diabetes-obesity duo Ozempic and Wegovy grab all the limelight, an oral version of the semaglutide drug showed it can provide heart-related benefits, too.

James Manning / PA Images / Getty Images After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its third-quarter sales fell short of ...

EU antitrust regulators to decide on Novo Holdings' Catalent buy by Dec. 6 Novo announced $16.5 billion acquisition in February Novo Nordisk seeking to boost output of Wegovy weight-loss drug ...